Cara Therapeutics, Inc.
4 Stamford Plaza
107 Elm Street, 9th Floor
Stamford, Connecticut 06902
April 26, 2022
Via EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Michael Davis
| Re: |
Request to Withdraw Acceleration Request of Cara Therapeutics, Inc., (the “Company”), dated April 22, 2022 for the Registration Statement on Form S-3 (File No. 333-263165) |
Mr. Davis,
On behalf of the Company, I hereby formally request the withdrawal of the acceleration request of Cara Therapeutics, Inc. with respect to the above referenced registration statement, submitted via Edgar on April 22, 2022.
Thank you for the Staff’s cooperation in connection with this matter.
| Very truly yours, | ||
| Cara Therapeutics, Inc. | ||
| By: |
/s/ Christopher Posner | |
| Christopher Posner | ||
| Chief Executive Officer and Director | ||
cc: Darren DeStefano, Cooley LLP